Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD)

Clinical and Experimental Immunology

Volumn 110, Issue 1, 1997, Pages 104-113

  Rugtveit, J ^a,c   Bakka, A ^b   Brandtzaeg, P ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Costimulatory molecules; Crohn's disease; Human intestinal mucosa; Macrophages; Ulcerative colitis

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD86 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOPEROXIDASE STAINING; IMMUNOREGULATION; INTESTINE MUCOSA; MACROPHAGE ACTIVATION; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

EID: 0030763573     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.507-ce1404.x     Document Type: Article

References (64)

1. Janeway CJ, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76:275-85.
2. Allison JP. CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994; 6:414-9.
3. Robey E, Allison JP. T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol Today 1995; 16:306-10.
4. Linsley PS, Ledbetter JA, The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11:191-212.
5. Lenschow DJ, Bluestone JA. T cell co-stimulation and in vivo tolerance. Curr Opin Immunol 1993; 5:747-52.
6. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today 1995; 16:374-9.
7. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73.
8. Mosmann R, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
9. Freeman GJ, Boussiotis VA, Anumamhan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 hut not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2:523-32.
10. Lenschow DJ, Ho SC, Sattar H et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181:1145-55.
11. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
12. Thompson CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995; 81:979-82.
13. Webb LM, Feldmann M. Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells. Blood 1995; 86:3479-86.
14. + T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2:271-9.
15. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16:34-38.
16. Matulonis U, Dosiou C, Freeman G et al. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol 1996; 156:1126-31.
17. Windhagen A, Newcombe J, Dangond F et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995; 182:1985-96.
18. Lanier LL, O'Fallon S, Somoza C et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154:97-105.
19. + T cells and induce similar patterns of cytokine secretion in vitro. Int Immunol 1995; 7:891-904.
20. Duchmann R, Kaiser I, Hermann E et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102:448-55.
21. Macpherson A, Khoo U, Forgacs I, Philpott-Howard JIB. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996; 38:365-75.
22. O'Morain CA, Abelow AC, Chervu LR, Fleischner GM, Das KM. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986; 108:430-5.
23. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81; 1607-13.
24. Pulford KA, Rigney EM, Micklem KJ et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989; 42:414-21.
25. Poulter LW, Campbell DA, Munro C, Janossy G. Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol 1986; 24:351-7.
26. Allison MC, Cornwall S, Poulter LW, Dhillon AP, Pounder RE. Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 1988; 29:1531-8.
27. Selby WS, Poulter LW, Hobbs S, Jewell DP, Janossy G. Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol 1983; 36:379-84.
28. Melian A, Beckman EM, Porcelli SA, Brenner MB. Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr Opin Immunol 1996; 8:82-88.
29. Brandtzaeg P, Halstensen TS, Huitfeldt H, Valnes K. Immunofluorescence and immunoenzyme histochemistry. In: Johnstone AP, Turner MW, eds. Immunochemistry 2 - a practical approach. Oxford: Oxford University Press, 1997:71-130.
30. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994; 35:669-74.
31. + monocyte derived cells. Gut 1995; 37:367-73.
32. Schriever F, Freedman AS, Freeman G et al. Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 1989; 169:2043-58.
33. Parwaresch MR, Radzun HJ, Hansmann ML, Peters KP. Monoclonal antibody Ki-M4 specifically recognizes human dendritic reticulum cells (follicular dendritic cells) and their possible precursor in blood. Blood 1983; 62:585-911.
34. Burgio VL, Fais S, Boirivant M, Perrone A, Pallone F. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995; 109:1029-38.
35. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108:1396-404.
36. Ohkusa T, Okayasu I, Tokoi S, Ozaki Y. Bacterial invasion into the colonic mucosa in ulcerative colitis. J Gastroenterol Hepatol 1993; 8:116-8.
37. Schmittel A, Scheibenbogen C, Keilholz U. Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocyles. Scand J Immunol 1995; 42:701-4.
38. Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997; 112:1493-505.
39. Kielian TL, Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology 1995; 29:187-205.
40. Fleischer J, Soeth E, Reiling N, Grage-Griebenow E, Flad H-D, Ernst M. Differential expression and function of CD80 (B7-1) and CD86 (B7-2), on human peripheral blood monocytes. Immunology 1996; 89:592-8.
41. Buelens C, Willems F, Pierard G, Delvaux A, Velu T, Goldman M. IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells. Adv Exp Med Biol 1995; 378:363-5.
42. Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 1997; 18:555-89.
43. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-9.
44. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81:301-5.
45. + T cells in inflammatory bowel disease. Gastroenterology 1991; 101: 1594-605.
46. Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992; 33:55-58.
47. Breese EJ, Braegger CP, Corrigan CJ, Walker SJ, MacDonald TT, Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78:127-31.
48. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-35.
49. + lamina propria (LP) lymphokine secretion protiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70.
50. Karttunnen R, Breese EJ, Walker SJ, MacDonald TT. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation. J Clin Pathol 1994; 47:1015-8.
51. Brown DR, Green JM, Moskowitz NH, Davis M, Thompson CB, Reiner SL. Limited role of CD28-mediated signals in T helper subset differentiation. J Exp Med 1996; 184:803-10.
52. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1991; 101:1020-30.
53. Pirzer U, Schonhaar A, Fleischer B et al. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 1991; 338:1238-9.
54. Trinchieri G, Scott P. The role of interleukin-12 in the immune response, disease and therapy. Immunol Today 1994; 15:460-3.
55. Gasini RV, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154:2434-40.
56. + dendritic cells. Proc Natl Acad Sci USA 1996; 93:2588-92.
57. + leucocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 1996; 59:208-18.
58. Marie I, Holt PG, Perdue MH, Bienenstock J. Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J Immunol 1996; 156:1408-14.
59. McWilliam AS, Nelson D, Thomas JA, Holt PG. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 1994; 179:1331-6.
60. Holt PG, Haining S, Nelson DJ, Sedgwick JD. Origin and steady-state turnover of class II MHC-hearing dendritic cells in the epithelium of the conducting airways. J Immunol 1994; 153:256-61.
61. Upham JW, Strickland DH, Bilyk N, Robinson BW, Holt PG. Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology 1995; 84:142-7.
62. Chelen CJ, Fang Y, Freeman GJ et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995; 95:1415-21.
63. Holt PG, Oliver J, Bilyk N et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993; 177:397-407.
64. Qiao L, Braunstein J, Golling M, Autschbach F, Muller P, Meuer S. Differential regulation of human T cell responsiveness by mucosal versus blood monocytes. Eur J Immunol 1996; 26:922-7.